Skip to content

A double blind pilot study testing the effectiveness of Biotene mouthwash versus Normal Saline mouthwash to reduce the symptoms associated with mucositis in high dose chemotherapy patients.

A double blind pilot study testing the effectiveness of Biotene mouthwash versus Normal Saline mouthwash to reduce the symptoms associated with mucositis in high dose chemotherapy patients.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000057684
Enrollment
24
Registered
2005-08-01
Start date
2006-02-18
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

One of the most painful and debilitating side effects of chemotherapy is mucoisits. Oral mucositis involves swelling, irritation, and ulceration of the lining of the mouth. Good mouth care including mouthwashes has been shown to relieve symptoms. Currently, there is no strong evidence to support the use of any mouthwash. This is a pilot study to test the mouthwash, Biotene. Patients (24) will receive either Normal Saline or Biotene mouthwashes. The following data will be collected from each group: 1) severity of mucositis, symptoms experienced and 3) compliance with mouth care. Patients will be randomly assigned and unaware of which mouthwash they are to receive.

Interventions

Biotene mouthwash 20mls four times a day for the period of 21 days

Sponsors

Auspharm Australia
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with acute leukaemia, high grade lymphoma, or any other disease that requires high dose chemotherapy and patients receiving an autogenic stem cell transplant 2. In patient of the study hospital and over the age of 18 years 3. Able to read and understand English 4. Agrees to use no other mouthwashes at time of inclusion into study 5. Agrees to participate in an RCT.

Exclusion criteria

1. Patients receiving radiation treatment to head or neck 2. Patients who have a psychiatric history or mental/physical impairment that would hinder the individual to comply with the intervention.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026